Invesco Biotechnology & Genome ETF
Limited financial coverage for PBE.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price momentum, earnings growth, overall quality, management decisions, and valuation.
- IPO
- 2005
- HQ
- Downers Grove, IL, US
Get TickerSpark's AI analysis on PBE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $295.93M
- Div Yield
- 1.42%
- 52W High
- $98.82
- 52W Low
- $70.01
- 50D MA
- $95.22
- 200D MA
- $85.99
- Beta
- 0.79
- RSI (14)
- 45
- Avg Volume
- 27.55K
No earnings-call transcripts are available for PBE yet.
- Free Float
- 0.0%
- Shares Outstanding
- 3.05M
- Float Shares
- 0
of shares held by institutions
101 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Morgan Stanley | 148.50K | ▲ 16.72K |
| United Capital Financial Advisers, LLC | 104.34K | ▲ 2.36K |
| Lpl Financial LLC | 92.32K | ▲ 5.58K |
| Ubs Group AG | 68.10K | ▼ 879 |
| Bank Of America Corp | 57.29K | ▼ 2.00K |
| Royal Bank Of Canada | 50.49K | ▼ 8.84K |
| Wells Fargo & Company/Mn | 38.56K | ▼ 744 |
| Gerber Kawasaki Wealth & Investment Management | 31.67K | ▼ 3.57K |
| Cetera Investment Advisers | 25.76K | ▲ 2.62K |
| Yhb Investment Advisors, Inc. | 23.14K | ▼ 1.25K |
| Envestnet Asset Management Inc | 22.25K | ▲ 888 |
| Institute For Wealth Management, LLC. | 20.22K | ▼ 50 |
Held by 2 ETFs
Biggest fund positions in PBE by dollar value.
Our PBE coverage
Recent articles, reports, and earnings notes.
No research on PBE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PBE report →PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors?
fool.com · Sep 15
iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy?
fool.com · Sep 9
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset?
fool.com · Aug 21
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
zacks.com · Aug 13
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style?
fool.com · Aug 12
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
zacks.com · Aug 12
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?
fool.com · Aug 1
VHT vs. PBE: Which Health Care ETF Is the Better Buy?
fool.com · Jul 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.